戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 results from sexually transmitted infection (trichomoniasis).
2 nfirmed by Gram stain with no candidiasis or trichomoniasis).
3  tests (NAATs) for diagnosis of BV, VVC, and trichomoniasis.
4 andidates for the treatment of Mz-refractory trichomoniasis.
5 te Trichomonas vaginalis that causes the STI trichomoniasis.
6 opment of specific Tv20S inhibitors to treat trichomoniasis.
7 I, 30-1851) and 4576 (95% UI, 13-30 355) for trichomoniasis.
8 form rational design of therapeutics against trichomoniasis.
9 fety of secnidazole vs placebo in women with trichomoniasis.
10 iterate women experience lower likelihood of trichomoniasis.
11 tiate novel insight into the epidemiology of trichomoniasis.
12 ts were tested for chlamydia, gonorrhea, and trichomoniasis.
13 aginosis (BV), vulvovaginal candidiasis, and trichomoniasis.
14 screened with pooled sera from patients with trichomoniasis.
15 al sexually transmitted infection in humans, trichomoniasis.
16 harge, candidiasis, bacterial vaginosis, and trichomoniasis.
17 ibuting to tissue damage and inflammation in trichomoniasis.
18 may play a role in the pathogenesis of human trichomoniasis.
19 ications for treatment of NGU and control of trichomoniasis.
20 etronidazole reductively in the treatment of trichomoniasis.
21 rasitic protozoan and the causative agent of trichomoniasis.
22  of men aged 18-59 years tested positive for trichomoniasis.
23 an's risk of acquiring HIV-1, gonorrhea, and trichomoniasis.
24 ected vaginal specimens for the diagnosis of trichomoniasis.
25 (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis.
26 BV but do not protect against VVC or vaginal trichomoniasis.
27 al candidiasis (VVC), and 7 acquired vaginal trichomoniasis.
28 ed light on how to better diagnose and treat trichomoniasis.
29 ), bacterial vaginosis (2 studies; n = 930), trichomoniasis (1 study; n = 779), and genital herpes (1
30 (16.2% [95% CI: 8.6% to 28.5%], n = 50), and trichomoniasis (12.9% [95% CI: 7.7% to 20.7%], n = 80);
31 8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9.3%] vs 261/1815 [14.4%]; rat
32 hlamydia, 18%; HSV-2, 4%; gonorrhea, 4%; and trichomoniasis, 3%.
33 ex virus type 2 (HSV-2), 14%; gonorrhea, 6%; trichomoniasis, 3%; and hepatitis B, 2%.
34 luding diagnoses of gonorrhea, chlamydia, or trichomoniasis (8.4%), pregnancy (11.2%), and parenthood
35  an anaerobic protozoan parasite that causes trichomoniasis, a common sexually transmitted disease wi
36  serious veterinary pathogen, causing bovine trichomoniasis, a sexually transmitted disease leading t
37 ital ulcer disease, bacterial vaginosis, and trichomoniasis among female partners.
38 sease, we recruited 521 female patients with trichomoniasis and 176 control subjects.
39 Approximately 70% of infections with HSV and trichomoniasis and 53% to 100% of extragenital gonorrhea
40    There was no significant association with trichomoniasis and age.
41 ccasional partner; and, in females, incident trichomoniasis and bacterial vaginosis.
42 findings suggest novel approaches to control trichomoniasis and warrant further studies of galectin-b
43 iasis, trichomoniasis vaginalis (hereafter, "trichomoniasis"), and colonization with Lactobacillus or
44 of incident STIs (gonorrhoea, chlamydia, and trichomoniasis) and 31% of teenage births in South Afric
45 ns (15 gonorrhea, 10 chlamydial infection, 3 trichomoniasis), and 4 had dual infections.
46 stic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes was performed in a hi
47  chlamydia, syphilis, Mycoplasma genitalium, trichomoniasis, and genital herpes.
48 nosis of gonorrhea, chlamydia, M genitalium, trichomoniasis, and symptomatic HSV-1 and HSV-2.
49 nucleic acid amplification tests (NAATs) for trichomoniasis are accurate, quick and confirmative with
50   The true prevalence and clinical impact of trichomoniasis are unknown, as current methods of detect
51     Sexually transmitted diseases, including trichomoniasis, are risk factors for acquisition of huma
52 arities are prominent in the epidemiology of trichomoniasis, as African Americans are >4 times more l
53 es along with the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.
54 pregnant women, the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chl
55 mpiric therapy for gonorrhea, chlamydia, and trichomoniasis based on updated treatment regimens; vacc
56               We screened pregnant women for trichomoniasis by culture of vaginal secretions.
57 imed to provide a more reliable diagnosis of trichomoniasis by investigating an association with leuk
58                                     Usually, trichomoniasis can be cured with single-dose therapy of
59                                  In females, trichomoniasis causes vaginitis, while in males, it is f
60 , 20%; specificity, 98%; PPV, 88%; NPV, 57%; trichomoniasis, colpitis macularis: sensitivity, 2%; spe
61                                   Women with trichomoniasis, confirmed by a positive T. vaginalis cul
62 reatment of pregnant women with asymptomatic trichomoniasis does not prevent preterm delivery.
63  to wet mount for point-of-care diagnosis of trichomoniasis, especially in settings where microscopy
64 andidiasis (HR, 0.84; 95% CI, 0.67-1.04) and trichomoniasis (HR, 0.55; 95% CI, 0.27-1.12) among treat
65 ection in male sexual partners of women with trichomoniasis identified by wet mount and culture.
66                               These included trichomoniasis in 16 women (11%); syphilis, 9 (6%); geni
67 o returned for at least one follow-up visit: trichomoniasis in 23 (18%); genital herpes, 20 (12%); go
68 bic flagellated protozoan, causes urogenital trichomoniasis in cattle.
69  is known about the epidemiologic profile of trichomoniasis in men and its relationship to human immu
70     Variations in estimates of prevalence of trichomoniasis in men may reflect true differences in th
71  uncertain whether treatment of asymptomatic trichomoniasis in pregnant women reduces the occurrence
72 oor sensitivity but is used for diagnosis of trichomoniasis in resource-poor settings.
73                            The prevalence of trichomoniasis in the population was 16.7% (502 of 3,009
74         We aim to estimate the prevalence of trichomoniasis in US males using the National Health and
75 ted for chlamydial infection, gonorrhea, and trichomoniasis in wave 3 (2001-2002) of the National Lon
76  Vaginal lactobacilli may be associated with trichomoniasis in women with higher levels of education
77 PCR-ELISA may be useful for the detection of trichomoniasis in women.
78  effects of human immunodeficiency virus and trichomoniasis, in Lilongwe, Malawi.
79  role for secnidazole in treating women with trichomoniasis, including those with HIV and/or BV.
80 omonas foetus, the causative agent of bovine trichomoniasis) induced a selective upregulation of chem
81  the causative agent of the venereal disease trichomoniasis, infects men and women globally and is as
82                                              Trichomoniasis is a common sexually transmitted disease
83                                       Bovine trichomoniasis is a sexually transmitted disease caused
84                                              Trichomoniasis is a sexually transmitted infection that
85                                              Trichomoniasis is a significant sexually transmitted dis
86 lly transmitted infections (STIs) in Malawi, trichomoniasis is not considered for first-line treatmen
87 The effect that vaginal lactobacilli have on trichomoniasis is not known.
88                                              Trichomoniasis is the most common non-viral sexually tra
89                                              Trichomoniasis is the most common nonviral sexually tran
90 nas vaginalis, the causative agent for human trichomoniasis, is a problematic sexually transmitted di
91 ncluding gonorrhea, syphilis, chlamydia, and trichomoniasis, is increasing by over 1 million new case
92 ncluding gonorrhea, syphilis, chlamydia, and trichomoniasis, is increasing by over 1 million new case
93 of vaginal lactobacilli were associated with trichomoniasis (odds ratio [OR], 2.2 [95% confidence int
94 ost due to genital chlamydia, gonorrhea, and trichomoniasis, per incident infection and at the popula
95                                              Trichomoniasis prevalence was inversely related to serum
96 ater likelihood of cervical inflammation and trichomoniasis relative to women in remote villages; wom
97 t in Spanish are also more likely to present trichomoniasis relative to women with moderate or no flu
98                                              Trichomoniasis remains the most common curable nonviral
99         Between randomization and follow-up, trichomoniasis resolved in 249 of 269 women for whom fol
100 amydia, syphilis, Mycoplasma genitalium, and trichomoniasis, respectively, but antimicrobial resistan
101 rhea, chlamydia, syphilis, M genitalium, and trichomoniasis, respectively, but antimicrobial resistan
102                                              Trichomoniasis results from adhesion of Trichomonas vagi
103 richomonas vaginalis, the causative agent of trichomoniasis [the most common nonviral sexually transm
104 rough the human genitourinary tract to cause trichomoniasis, the most common non-viral sexually trans
105 ated protozoan, is the agent responsible for trichomoniasis, the most common nonviral sexually transm
106 andidiasis, bacterial vaginosis, and vaginal trichomoniasis using some combination of physical examin
107 years, the survey included urine testing for trichomoniasis using transcription-mediated amplificatio
108 cterial vaginosis (BV), vaginal candidiasis, trichomoniasis vaginalis (hereafter, "trichomoniasis"),
109                                              Trichomoniasis vaginalis is the most common nonviral sex
110                                              Trichomoniasis vaginalis, the most prevalent nonviral se
111                                              Trichomoniasis was associated only with having a new sex
112                                              Trichomoniasis was associated with a 1.52-fold (95% conf
113 ected vaginal specimens for the diagnosis of trichomoniasis was conducted.
114 nts with gonorrhea, chlamydial infection, or trichomoniasis were compared with specimens from 32 clin
115 TI clinic, urethral symptoms attributable to trichomoniasis were more severe among HIV-positive men t
116 andomly assigned 617 women with asymptomatic trichomoniasis who were 16 to 23 weeks pregnant to recei
117 ntribute to the epidemiologic association of trichomoniasis with the sexual transmission of HIV-1.
118 Mz) and tinidazole are approved for treating trichomoniasis, yet resistance is a clinical problem.

 
Page Top